Literature DB >> 33745915

Renal artery stenosis.

Robert D Safian1.   

Abstract

Renal artery stenosis is the most common secondary cause of hypertension and predominantly caused by atherosclerosis. In suspected patients, a non-invasive diagnosis with ultrasound is preferred. Asymptomatic, incidentally found RAS does not require revascularization. In symptomatic patients requiring revascularization, renal artery stenting is the preferred therapy. Selecting appropriate patients for revascularization requires careful consideration of lesion severity and is optimized with a multidisciplinary team. All patients with atherosclerotic RAS should be treated with guideline-directed medical therapy, including hypertension control, diabetes control, statins, antiplatelet therapy, smoking cessation and encouraging activity.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fibromuscular dysplasia; HTN; Ischemic nephropathy; Renal artery stenosis

Year:  2021        PMID: 33745915     DOI: 10.1016/j.pcad.2021.03.003

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  4 in total

1.  The Maintained Glycemic Target Goal and Renal Function Are Associated with Cardiovascular and Renal Outcomes in Diabetic Patients Following Stent-Supported Angioplasty for Renovascular Atherosclerotic Disease.

Authors:  Rafał Badacz; Anna Kabłak-Ziembicka; Agnieszka Rosławiecka; Daniel Rzeźnik; Jakub Baran; Mariusz Trystuła; Jacek Legutko; Tadeusz Przewłocki
Journal:  J Pers Med       Date:  2022-03-28

2.  Ultrasonographic Assessment of Atherosclerotic Renal Artery Stenosis in Elderly Patients with Chronic Kidney Disease: An Italian Cohort Study.

Authors:  Yuri Battaglia; Fulvio Fiorini; Pietro Gisonni; Massimo Imbriaco; Paolo Lentini; Matthias Zeiler; Luigi Russo; Michele Prencipe; Domenico Russo
Journal:  Diagnostics (Basel)       Date:  2022-06-13

3.  Correlation of renal cortical blood perfusion and BP response after renal artery stenting.

Authors:  Siyu Wang; Sijie Zhang; Yan Li; Na Ma; Mengpu Li; Hu Ai; Hui Zhu; Junhong Ren; Yongjun Li; Peng Li
Journal:  Front Cardiovasc Med       Date:  2022-10-03

4.  IL-10 partly mediates the ability of MSC-derived extracellular vesicles to attenuate myocardial damage in experimental metabolic renovascular hypertension.

Authors:  Yamei Jiang; Siting Hong; Xiangyang Zhu; Lei Zhang; Hui Tang; Kyra L Jordan; Ishran M Saadiq; Weijun Huang; Amir Lerman; Alfonso Eirin; Lilach O Lerman
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.